BofA cuts CRISPR Therapeutics stock price target to $83 on valuation Business May 5, 2026adminLeave a Comment on BofA cuts CRISPR Therapeutics stock price target to $83 on valuation Advertisements BofA cuts CRISPR Therapeutics stock price target to $83 on valuation Advertisements